2010;33:1192 8. S9.3-20. Terawaki H, Metoki H, Nakayama M, et al. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study. Hypertens Res. 2008;31:2129 35. S9.3-21. Minutolo R, Gabbai FB, Agarwal R, et al. Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. Am J Kidney Dis. 2014;64:744 52. S9.3-22. Drawz PE, Alper AB, Anderson AH, et al. Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016;11:642 52. S9.3-23. Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:1175 80. S9.3-24. Navaneethan SD, Schold JD, Arrigain S, et al. Cause-specific deaths in non-dialysis-dependent CKD. J Am Soc Nephrol. 2015;26:2512 20. S9.3-25. Matsushita K, van der Velde M, Astor BC, et al. Association of esti- mated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collabora- tive meta-analysis. Chronic Kidney Disease Prognosis Consortium. Lancet. 2010;375:2073 81. S9.3-26. Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. SPRINT Research Group. N Engl J Med. 2015;373:2103 16. S9.3-27. Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. ACCORD Study Group. N Engl J Med. 2010;362:1575 85. S9.3-28. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S49 73. S9.3-29. Kovesdy CP, Alrifai A, Gosmanova EO, et al. 